Tokyo Joe's Cafe / Societe Anonyme/No Pennies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JEB who wrote (26878)	12/12/1998 7:57:00 AM
From: Donna Carey	Read Replies (2) of 119973

JEB, all, ASTM This was taken from Astrom's home page: "The AastromReplicell™ System is being used in a trial at Duke University Medical Center (under the direction Kurtzberg, M.D.) to increase the number of transplantable cord blood cells in an effort to improve recovery outcomes in children with these types of otherwise fatal blood diseases. This trial, conducted under an FDA Investigational Device Exemption, was expanded this year based on positive initial results. A similar clinical study, using AastromReplicell™ System-expanded cord blood cells for adult cancer patients, is also underway at Loyola University Medical Center in Chicago and Hackensack Medical Center in New Jersey." This is the same Dr. Joanne Kurtzberg of Duke University in the report given on the NBC Nightly News segment earlier this week. (Found it on the MSNBC website) Note also that Duke University is also mentioned in the BBC URL that you gave JEB. I don't know what will happen Monday, but the more I research this, the more I like it longer term. Donna

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next